Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Clinical trial NCT00301873 · COMPLETED

Trial details

NCT number: NCT00301873
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Tumors Osteoporosis Central Nervous System(CNS)Malignancies

Start date: 2006-05-01
Primary completion: 2011-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.